Plan Nacional De Contingencia Para Enfrentar Posible Pandemia De Influenza En El Ecuador

Objectives

Establish a national, intersectoral contingency framework to protect Ecuador’s population from the social, economic and health consequences of an influenza pandemic, maintain the country’s avian-influenza-free status, reduce pandemic risk, and support prevention, response and recovery.[1][2]The framework seeks to mitigate and restore population health through appropriate sanitary conditions, timely effective care, and full participation by health-sector, other-sector and community actors at national, sub-national and local levels.[3]

• Strengthen preparedness during the interpandemic period at global, regional, national and sub-national levels, reduce the risk of human transmission, rapidly detect and report transmission, contain or delay spread during alert phases, and minimise impacts during a pandemic.[4]
• Integrate human, animal and environmental health action, recognising avian influenza and the risk that H5N1 could acquire efficient person-to-person transmission.[1][5]
• Develop surveillance for human and avian influenza, including sentinel surveillance, virus characterisation, laboratory diagnosis, migratory-bird monitoring, epidemiological tracing and post-elimination surveillance.[2][6][7]
• Protect high-risk groups through seasonal influenza vaccination, including older people, people with chronic conditions, young children, pregnant women, long-term-care residents, healthcare workers and household members of high-risk people.[8]
• Improve health-service readiness by defining levels of care, referral and counter-referral arrangements, hospital capacity, staffing, emergency plans, supplies, antiviral availability and clinical protocols.[9][10][11]
• Strengthen public information, education, communication and social mobilisation to support protective behaviour, public confidence and informed decisions without generating panic.[1][12][13]
• Address health-system weaknesses, including fragmentation, inequitable access, inadequate coverage and quality, low public financing, inefficient expenditure, and weak prevention and mitigation culture.[3]

Implementation

Implement the plan through coordinated national emergency and disaster-management structures, combining health, agricultural health, environmental, civil-defence, laboratory, health-service, communications and community capacities.[14][15][2]Ecuador’s Civil Defence System provides the official disaster-management structure across political and administrative levels, while the National Directorate of Civil Defence links national institutions with provincial, cantonal, parish and special-zone bodies.[15]

• Coordinate institutions through the Ministry of Public Health, Ministry of Agriculture and Livestock, Ecuadorian Agricultural Health Service, Ministry of the Environment, Civil Defence, and supporting organisations including the Pan American Health Organization and the Food and Agriculture Organization of the United Nations.[14][1][2]
• Use the Health Emergency Operations Committee to promote, plan and maintain joint response coordination among institutions, jurisdictions and operational levels.[3]Operationalise the National Council for Emergency Health and develop the National Health Network for Emergency and Disaster Care under the Ministry of Health’s risk-management process.[16]
• Manage pandemic response as a national-security matter during the response phase, applying emergency legislation and contingency plans with support from the Red Cross, firefighters, police, armed forces and other sectors.[17]
• Assign avian-influenza surveillance and agricultural sanitary control to agricultural authorities, while health authorities protect the human population and manage human case detection, notification and care.[1][18]
• Lead agricultural-health action through the Interministerial Committee for the Control and Eradication of Avian Influenza, chaired by the Ecuadorian Agricultural Health Service, to define responsibilities, issue sanitary resolutions, deploy personnel, establish tracing areas and obtain international technical advice.[6]
• Activate the Sistema de Vigilancia Epidemiológica Zoosanitaria for outbreak investigation, farm inspection, sampling, laboratory referral, information analysis and continuing control of affected areas.[19]Apply movement restrictions, traffic controls, permits where necessary, washing and disinfection measures, and sanitary procedures for infected, quarantine and surveillance areas.[6][19]
• Operate human influenza sentinel surveillance in Pichincha, Guayas and Azuay, refer cases for specialist clinical and laboratory assessment, follow cases and contacts, and use morbidity and mortality data to inform vaccine formulation, public-health action and service planning.[7]
• Maintain immediate notification of suspected and confirmed human cases through SIVE ALERTA, alongside daily or weekly notifications according to the epidemiological stage, weekly negative reporting, and immediate notification of animal cases.[2][18][7][20]
• Strengthen laboratory capacity through immunofluorescence, culture, viral isolation, antigenic characterisation, molecular testing, a national strain bank, validated rapid tests and authorised diagnostic laboratories.[21][19][22]Separate avian and human sample-processing environments, coordinate laboratories with epidemiology, and standardise specimen transport and biosafety arrangements.[23][24]
• Organise clinical delivery by care level, with first-level units providing ambulatory care and referral, higher-complexity hospitals initially receiving admitted patients, and basic hospitals receiving patients after bed redistribution if capacity is exceeded.[9][10]Monitor beds and anticipated discharges daily during the expected admission peak.[10]
• Prepare reserves and procurement arrangements for medical supplies, personal protective equipment, antivirals, biological products and treatments for complications.[25][10]Pandemic vaccine procurement is envisaged through the Butantan Institute in São Paulo because Ecuador does not produce vaccine.[22][25]
• Deliver communication through national, provincial and local institutions, media, professional bodies, poultry-sector organisations and operational services; maintain media databases, train officials, analyse the information environment weekly, and use designated official spokespeople.[12][26]

Monitoring & Evaluation

The plan combines human and animal influenza surveillance, laboratory confirmation, phased pandemic detection, operational monitoring and communication oversight, but provides limited formal performance measurement or accountability detail.[14][4][2]

• Organise influenza surveillance according to participating institutions’ responsibilities, with agricultural authorities leading avian influenza surveillance and health authorities protecting the human population.[14][1]
• Maintain pre-pandemic surveillance of avian and human influenza, including permanent monitoring of migratory birds, wetlands near poultry holdings, representative sampling, epidemiological tracing and post-elimination surveillance.[2][17][6]
• Operate the Sistema de Vigilancia Epidemiológica Zoosanitaria to collect, consolidate and interpret outbreak data, investigate farms, undertake inspections and necropsies, manage sampling and laboratory submission, recommend control measures, and report information to the Comisión Nacional de Avicultura.[19]
• Strengthen sentinel surveillance in Pichincha, Guayas and Azuay to characterise circulating human influenza viruses during the inter-pandemic period and establish additional avian and human influenza sentinel sites during epidemic alerts.[7]
• Use morbidity and mortality data, virus isolation and antigenic characterisation to identify epidemics early, inform vaccine formulation, guide public-health action, anticipate impacts on essential services, and estimate the effects of outbreaks and control measures.[7]
• Classify human cases as presumptive, probable or confirmed on the basis of clinical presentation, exposure history and laboratory evidence.[18][7]
• Notify suspected and confirmed human cases immediately through SIVE ALERTA, submit clinical and epidemiological investigation forms, report negative human cases weekly, and notify animal cases immediately through provincial agricultural health coordination units.[2][18]
• Collect minimum case data through the Influenza Clinical and Epidemiological Investigation Form and submit notifications daily or weekly according to the epidemiological phase, alongside weekly negative reporting.[7][20]
• Confirm cases through laboratory testing, including antigen detection, viral isolation, haemagglutination inhibition, paired-serum serology, enzyme-linked immunosorbent assay, agar gel precipitation and conventional or real-time reverse transcription polymerase chain reaction.[27][28][19]
• Maintain authorised diagnostic laboratories, with the Instituto de Higiene “Izquieta Pérez” as the principal laboratory and support from Lafavet, Anhalzer and PRONACA.[21]
• Systematically notify immunofluorescence, culture and haemagglutination-inhibition results, refer positive immunofluorescence samples to the Guayaquil laboratory for culture and confirmation, and standardise specimen transport.[23][24]
• Validate molecular and rapid-testing methods against sensitivity, specificity, predictive values, conditions of use, conservation and cost-effectiveness criteria, while reactivating external assessment through Flu-Net.[22]
• Use phase-based milestones to detect novel viral subtypes, human infection, person-to-person transmission and geographic clustering, and prioritise rapid notification and response during alert periods.[4]
• Monitor hospital beds and anticipated discharges daily, especially during the pandemic’s first month, and require facilities to document operational limitations with relevant health authorities.[9][10]
• Regulate disaster information through the National Directorate of Civil Defence and relevant bodies, and conduct weekly communication-context analysis with findings and recommendations submitted to the General Technical Committee.[16][13][26]

Formal quantitative indicators, performance targets, evaluation schedules, independent review arrangements and comprehensive accountability mechanisms are not specified, apart from designated institutional responsibilities, laboratory oversight, notification requirements, phase-based actions and operational monitoring.[29][21][20][9]

Costing & Financing

Financing arrangements are largely unquantified. The plan identifies low public health financing, inefficient expenditure, rising healthcare costs and the need for substantial preparedness resources, while specifying only an estimated seasonal vaccination cost and general emergency funding mechanisms.[29][3][22]

• Use the Civil Defence Contingency Fund for disaster-prevention works and responses to national or international emergencies.[16]
• Assign extra-budgetary resources to a presidentially authorised emergency budget for assistance to populations in officially declared emergency areas.[16]
• Manage national and international disaster donations through the National Directorate of Civil Defence.[16]
• Plan seasonal influenza vaccination for priority groups using 1,100 adult doses and 450,000 paediatric doses, at an estimated total cost of 3 million US dollars.[22]
• Procure pandemic vaccine externally through the Butantan Institute in São Paulo because Ecuador does not produce vaccines nationally.[22][25]
• Recognise that pandemic-vaccine access depends on strain characterisation and that production may take up to eight months.[22][25]
• Establish strategic reserves of specific supplies, medicines, antiviral treatments and treatment for complications, while recognising limited national and global antiviral availability.[25]
• Provide diagnostic kits, antigens, authorised laboratories and additional trained veterinarians according to operational need for avian influenza diagnosis and control.[21][19]
• Prepare contingency arrangements for staffing, emergency volunteers, medical supplies, personal protective equipment, biological products, antiviral medicines, procurement, storage and distribution.[10][11]

An international estimate suggests that a pandemic could reduce global gross domestic product by 0.2%.[1]Country estimates suggest that approximately 64,000 people could require hospitalisation and around 35,000 could die, but no associated national financial costing is provided.[5]

The source does not specify a comprehensive national budget, programme allocations, funding-gap estimate, compensation scheme, unit costs, financing plan, resource-mobilisation targets or detailed economic assumptions for pandemic implementation.[3][21][7][10]